[Skip to Content]
[Skip to Content Landing]
Article
September 1987

Serum Protein Electrophoresis Patterns in Chronic Lymphocytic LeukemiaClinical and Epidemiologic Correlations

Author Affiliations

From the Division of Internal Medicine, Stony Brook (NY) School of Medicine (Dr Miller); the Department of Epidemiology, Johns Hopkins School of Hygiene and Public Health (Dr Linet, Mr Van Natta, and Ms McCaffrey), and Johns Hopkins Oncology Center (Dr Humphrey), Baltimore.

Arch Intern Med. 1987;147(9):1614-1617. doi:10.1001/archinte.1987.00370090090016
Abstract

• Serum protein electrophoresis (SPEP) data obtained at diagnosis were available for 98 of 342 patients with chronic lymphocytic leukemia (CLL) identified in a population-based case-control epidemiologic study. Patients tested with SPEP at diagnosis were significantly younger, more likely to have lymphadenopathy, and more likely to have had their conditions diagnosed at a university hospital than those not tested. Four categories of electrophoretic patterns were identified: normal (N=56), hypogammaglobulinemia (N=28), hypergammaglobulinemia (N=11), and monoclonal gammopathy (N=3). A higher proportion of those with hypergammaglobulinemia were black, and patients with hypergammaglobulinemia and monoclonal gammopathy were more likely to die within the first year following diagnosis than patients in the other SPEP groups. No association was found, however, between SPEP pattern and a clinical staging classification for CLL. These findings suggest that SPEP may be a useful adjunct in categorizing possible subtypes of CLL and developing future clinical staging classifications.

(Arch Intern Med 1987;147:1614-1617)

×